RUNX3 and esophageal cancer: Consistent with our study, oncomine data analysis also revealed RUNX3 and EZH2 up-regulation in five studies on esophageal cancer, OncomineTM (Compendia Bioscience, Ann Arbor, MI) was used for analysis and visualization (Figs. 5, 6).